Prostate cancer spreads to bones first, then lymph nodes and distant organs
When prostate cancer metastasizes—spreads beyond the prostate gland—it follows predictable patterns. Bone is by far the most common destination, appearing in roughly 90 percent of men with metastatic prostate cancer. The pelvis, spine, ribs, and femur (thighbone) are hit most often. After bone, the next most frequent sites are the regional lymph nodes near the prostate, followed by the lungs, liver, and adrenal glands. The brain is involved in only about 1 percent of cases, making it the rarest site.
This pattern matters because where cancer spreads determines what symptoms you might notice, which imaging tests your doctor will order, and how treatment changes. A man with bone metastases faces different challenges than one with lung involvement. Understanding these patterns also helps explain why certain screening and monitoring approaches make sense at different stages of the disease.
Key Takeaways
- Bone metastases occur in the majority of men with advanced prostate cancer, with the pelvis and spine being the most common bones affected.
- Prostate cancer typically spreads to nearby lymph nodes before traveling to distant organs, following a somewhat predictable sequence.
- Lung, liver, and adrenal gland involvement happens less often than bone disease but still occurs in a meaningful fraction of advanced cases.
- Where cancer spreads influences which symptoms develop, what imaging your doctor orders, and which treatments become relevant.
Why bone is the preferred site for prostate cancer spread
Bone metastases dominate in prostate cancer for biological reasons that researchers are still working to fully understand. Prostate cancer cells appear to have a particular affinity for bone marrow—they thrive in that environment in ways they do not in other tissues. The bone surface also provides a rich supply of growth factors and proteins that feed cancer cell growth.
The specific bones affected follow a pattern tied to blood flow and bone marrow density. The pelvis receives heavy blood supply and contains abundant marrow, making it a frequent landing spot. The lumbar spine (lower back) and thoracic spine (mid-back) come next. The ribs, femur, and humerus (upper arm bone) are also common. Bone metastases in the skull and jaw are much rarer.
Bone involvement often produces pain—typically in the lower back, pelvis, or hips—though some men have no symptoms at all and discover bone metastases only through imaging done for other reasons. Bone metastases can also weaken the skeleton enough to cause fractures from minor falls or even spontaneous breaks.
Lymph node involvement and what it signals
The lymph nodes nearest the prostate—called regional lymph nodes—are often the first place cancer spreads. These nodes sit in the pelvis alongside the prostate and receive lymphatic drainage directly from the gland. When cancer reaches these nodes, it signals that the disease has begun to escape the prostate itself but has not yet traveled far.
Regional lymph node involvement is detected through imaging (CT scans or MRI) or sometimes discovered during surgery. Finding cancer in these nodes changes the stage of the disease and usually prompts a shift toward systemic treatment—drugs that circulate through the whole body rather than local approaches like surgery or radiation.
Distant lymph nodes—those in the abdomen, chest, or elsewhere—are less common but do occur. When cancer reaches distant nodes, it indicates more advanced disease and typically means other metastatic sites are present or will develop.
Lung, liver, and adrenal gland metastases
After bone and regional lymph nodes, the lungs are the next most common site for prostate cancer spread, though they are involved in only a fraction of metastatic cases. Lung metastases may cause no symptoms, or they may trigger a persistent cough, chest pain, or shortness of breath. They are usually detected on CT imaging of the chest.
Liver metastases occur less frequently than lung involvement. When present, they can cause abdominal pain, swelling, or elevated liver enzymes on blood tests. The adrenal glands—small hormone-producing organs that sit atop the kidneys—are another less common site. Adrenal involvement is often found incidentally on imaging done to look for other metastases.
The presence of lung, liver, or adrenal metastases generally indicates more aggressive disease and typically means bone metastases are also present. These sites are usually detected through CT or PET imaging rather than through symptoms alone.
Brain metastases and other rare sites
Brain metastases from prostate cancer are uncommon, occurring in roughly 1 percent of men with metastatic disease. When they do happen, they tend to appear late in the disease course and often signal that cancer is present in multiple other organs as well. Brain metastases can cause headaches, neurological symptoms, or cognitive changes, though some are found on imaging before symptoms develop.
Other rare sites include the stomach, colon, pancreas, and skin. Metastases to these organs are unusual enough that when they occur, doctors often need to confirm that the cancer truly originated in the prostate rather than in the organ where it was found. Peritoneal metastases—cancer spread to the lining of the abdominal cavity—are also rare in prostate cancer.
How doctors detect where cancer has spread
Imaging is the primary tool for finding metastases. CT scans of the pelvis, abdomen, and chest can show lymph node enlargement, lung nodules, and organ involvement. Bone scans (also called skeletal scintigraphy) use a radioactive tracer to highlight areas of bone turnover, making bone metastases visible. MRI provides detailed images of the spine and pelvis and is particularly useful for detecting bone marrow involvement.
PET scans using tracers like fluorodeoxyglucose (FDG) or choline can show areas of high metabolic activity where cancer is present. Some PET tracers are more specific to prostate cancer than others. Blood tests measuring PSA (prostate-specific antigen) and alkaline phosphatase can suggest bone involvement, though imaging is needed to confirm location and extent.
The choice of imaging depends on the clinical situation, PSA level, and what the doctor is trying to determine. A man with a rising PSA after initial treatment may get different imaging than one presenting with bone pain.
What metastatic pattern means for treatment and prognosis
Where cancer has spread influences which treatments are offered. Men with bone-only metastases may receive hormone therapy, chemotherapy, or newer drugs designed specifically for metastatic prostate cancer. Bone-targeting drugs like zoledronic acid or denosumab are often added to reduce pain and fracture risk. Men with visceral metastases (lung, liver, adrenal) often move more quickly to chemotherapy and may have a shorter life expectancy than those with bone-only disease.
The number of metastatic sites also matters. Men with a single metastasis or a few metastases in one location (called oligometastatic disease) sometimes receive local treatment—surgery or radiation to the metastatic site—in addition to systemic therapy. Men with widespread metastases across multiple organs typically receive systemic treatment alone.
Prognosis varies widely based on the extent of spread, the aggressiveness of the cancer cells, and how the cancer responds to initial treatment. Some men live for years with metastatic disease, while others progress more rapidly. Your doctor can discuss what the specific pattern of spread means for your individual situation.
Frequently Asked Questions
Can prostate cancer spread to the brain?
Brain metastases from prostate cancer are rare, occurring in about 1 percent of men with metastatic disease. When they do happen, they usually appear late in the disease course and often alongside metastases in other organs. Brain involvement is typically detected on MRI or CT imaging.
Why does prostate cancer go to bone so often?
Prostate cancer cells have a biological preference for bone marrow—they thrive in that environment better than in other tissues. Bone also provides abundant growth factors and proteins that feed cancer cell growth. The pelvis and spine receive heavy blood flow and contain rich marrow, making them frequent targets.
If cancer is in my lymph nodes, does that mean it's in my bones too?
Not necessarily. Regional lymph node involvement can occur before bone metastases develop. However, if distant lymph nodes are affected, other metastatic sites are usually present or will develop. Your doctor can review your specific imaging to determine what sites are involved.
What does it mean if prostate cancer spreads to the lungs?
Lung metastases indicate more advanced disease and typically mean bone metastases are also present. Lung involvement is usually detected on CT imaging and may cause a cough or chest pain, though some men have no symptoms. Treatment typically involves systemic drugs that circulate through the whole body.
How quickly does prostate cancer spread to other parts of the body?
The speed of spread varies widely depending on how aggressive the cancer cells are. Some men have slow-growing cancer that takes years to metastasize, while others develop metastases more quickly. Your PSA level, Gleason score, and how the cancer responds to initial treatment all influence the pace of spread.